Dr. Christopher R. Marsh

Hongmei Liang, MD, PhD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center at UPMC St. Margaret. Board certified in internal medicine and medical oncology, Dr. Liang received her medical degree from Shandong Medical University, Jinan in Shandong, China and PhD in immunology at the University of Pittsburgh School of Medicine. She completed her residency in internal medicine at Greater Baltimore Medical Center in Maryland and fellowship in hematology and oncology at the University of Pittsburgh Medical Center. Dr. Liang is rated as an Advanced provider by MediFind in the treatment of Lymphoid Hyperplasia. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Childhood Iron Deficiency Anemia, and Pleuropulmonary Blastoma.

John P. Morcos, MD, is a medical oncologist at Arnold Palmer Medical Oncology at Mt. Pleasant. Board-certified in hematology, oncology, and internal medicine, Dr. Morcos received his medical degree from Duke University School of Medicine. He completed his residency at Johns Hopkins Hospital in Baltimore and his fellowship at UPMC Hillman Cancer Center. Dr. Morcos is rated as a Distinguished provider by MediFind in the treatment of Lymphoid Hyperplasia. His top areas of expertise are Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Familial Colorectal Cancer, and Small Cell Lung Cancer (SCLC).

Kiran Kumar Rajasenan, MD, is a medical oncologist at UPMC Hillman Cancer Center, Wexford. Board-certified in internal medicine and medical oncology, Dr. Rajasenan received his medical degree from Hahnemann Medical College, now Drexel University College of Medicine in Philadelphia. He completed his residency at Allegheny General Hospital in Pittsburgh. Dr. Rajasenan is rated as an Advanced provider by MediFind in the treatment of Lymphoid Hyperplasia. His top areas of expertise are Non-Hodgkin Lymphoma, Small Cell Lung Cancer (SCLC), Lung Cancer, and Pleuropulmonary Blastoma.